Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.94 |
| ▸ | CA1 | P00915 | 3/20 | 0.94 |
| ▸ | CA12 | O43570 | 1/20 | 0.94 |
| ▸ | CA3 | P07451 | 1/20 | 0.94 |
| ▸ | TYR | P14679 | 1/20 | 0.94 |
| ▸ | DRD1 | P21728 | 1/20 | 0.94 |
| ▸ | CA4 | P22748 | 1/20 | 0.94 |
| ▸ | CA6 | P23280 | 1/20 | 0.94 |
| ▸ | CA5A | P35218 | 1/20 | 0.94 |
| ▸ | CA7 | P43166 | 1/20 | 0.94 |
| ▸ | CA9 | Q16790 | 1/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.94 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.94 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.80 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Paraben SCHEMBL8851008 | 1.00 | CA2 (0.94) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL27691660 | 0.97 | CA2 (0.89) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL7622776 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Terephthalic Acid SCHEMBL6692916 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL3212865 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL5311518 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Terephthalic Acid SCHEMBL3460105 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL4110 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL20500516 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL2838755 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230380428-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEV LLC (US) | 2023-11-30 | — | — | US | claimed |
| US-11446256-B1 | Aqueous wound healing formulation | ADVANTICE HEALTH, LLC (US) | 2022-09-20 | — | — | US | claimed |
| WO-2022081174-A1 | BIODEGRADABLE CLEANING PRODUCTS, METHODS OF PRODUCTION, AND THEIR COMPOSITIONS | SUSTAINABLE COMMUNITY DEVELOPMENT, LLC (US) | 2022-04-21 | — | — | WO | claimed |
| WO-2020226482-A1 | SYNERGISTIC COMPOSITIONS FOR CONTROLLING PLANT PATHOGENS WITH CHITINOLYTIC MICROORGANISMS / ORGANIC ACID COMBINATIONS AND METHOD OF USE THEREOF | LAI HONG HENG (MY) | 2020-11-12 | — | — | WO | claimed |
| US-20160303143-A1 | SOLID FORM OF ABIRATERONE ACETATE | BASF SE (DE) | 2016-10-20 | — | — | US | claimed |
| EP-3080141-A1 | SOLID FORM OF ABIRATERONE ACETATE | BASF SE (DE) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086596-A1 | SOLID FORM OF ABIRATERONE ACETATE | BASF SE (DE) | 2015-06-18 | — | — | WO | claimed |
| US-8937085-B2 | Pharmaceutical carrier composition and pharmaceutical composition | DAFRA PHARMA N.V. (BE) | 2015-01-20 | — | — | US | claimed |
| EP-2114372-B1 | PHARMACEUTICAL CARRIER COMPOSITION AND PHARMACEUTICAL COMPOSITION | DAFRA PHARMA N V (BE) | 2014-05-21 | — | — | EP | claimed |
| US-20110031261-A1 | MEDICATION DISPENSING SYSTEM AND METHOD OF USING SAME | BLISTEX INC. | 2011-02-10 | — | — | US | claimed |
| WO-2001096412-A1 | A CATALYST FOR ETHYLENE HOMO- AND COPOLYMERIZATION | SAMSUNG GENERAL CHEMICALS CO. LTD. (KR) | 2001-12-20 | — | — | WO | claimed |
| WO-2001092345-A1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-12-06 | — | — | WO | claimed |
| US-20010031694-A1 | Catalyst for polymerization and co-polymerization of ethylene | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-10-18 | — | — | US | claimed |
| WO-2001040320-A1 | CATALYST FOR POLYMERIZATION AND CO-POLYMERIZATION OF ETHYLENE | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-06-07 | — | — | WO | claimed |
| WO-2001032795-A1 | CYANOACRYLATE SOLUTIONS CONTAINING PRESERVATIVES | CLOSURE MEDICAL CORPORATION (US) | 2001-05-10 | — | — | WO | claimed |
| WO-2000073356-A1 | A CATALYST FOR ETHYLENE HOMO- AND CO-POLYMERIZATION | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2000-12-07 | — | — | WO | claimed |
| WO-2000073355-A1 | A CATALYST FOR ETHYLENE HOMO- AND CO-POLYMERIZATION | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2000-12-07 | — | — | WO | claimed |
| US-6146560-A | Process for forming an article from recycled ceramic molding compound | GLAS USA LLC | 2000-11-14 | — | — | US | claimed |
| EP-0410348-A1 | Topical spironolactone composition | G.D. Searle & Co. (US) | 1991-01-30 | — | — | EP | claimed |
| US-4406827-A | CROSSLINKED GUM, IONIXED SALT, BIOMEDICAL ELECTRODE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160303143-A1 | SOLID FORM OF ABIRATERONE ACETATE | AR, SRD5A1, SRD5A2 | CA2 1510/4885CA1 511/4885CA12 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.